BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer
AstronauTx appoints Adam Rosenberg as Chair of the Board
Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer
Angelini Pharma appoints Sergio Marullo di Condojanni as CEO
QV Bioelectronics secures £4.5m in funding for brain cancer therapy development